EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy

David J McFall iD, Abbas I Hussain, Michelle Cho, Patrick A Forcelli iD

Epilepsia · 2026-07 · 67 (7) · 3779-3790

DOI: 10.1002/epi.70226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 13.04.2026. Verfasst von David J McFall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC, USA. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Senotherapeutics, Cellular Senescence, Behavior, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Current pharmacotherapy for temporal lobe epilepsy (TLE) is limited to symptomatic treatment and leaves approximately one third of patients with inadequate seizure control. Discovering disease‐modifying targets is an unmet clinical need. We have previously identified senescent cells (SCs) as one such target. Many drugs that eliminate SCs ( senolytics ) interfere with apoptotic resistance proteins, potentially resulting in broad cytotoxicity and numerous side effects. Newer, more targeted therapies, like selective senescence killing compound 1 (SSK1), a gemcitabine prodrug that is selectively activated in SCs, offer the possibility to reduce off‐target effects, but SSK1 has yet to be investigated in any preclinical epilepsy model.

Methods

We used pilocarpine to induce status epilepticus (SE) in 3‐ to 4‐month‐old mice. Immediately following SE, mice were randomly assigned to receive either SSK1 treatment or vehicle for the remainder of the study. We assessed behavioral performance on memory tasks, seizure burden by EEG, and histological markers of SCs.

Results

SE robustly increased hippocampal and thalamic expression of SC marker p16 by over 100% compared to saline controls. SSK1 treatment reduced p16+ cells by ~45%, without any apparent neurotoxicity. In addition, SSK1 treatment normalized spatial memory impairments and reduced spontaneous seizure burden, completely protecting a majority (60%) of animals from seizures. SC burden in the hippocampus, but not the thalamus, correlated with seizure burden in vehicle‐treated animals. Significance These findings lend further credence to the viability of targeting SCs to treat TLE. As with other genetic and pharmacologic SC ablation strategies, SSK1 produced a similar reduction in p16+ cells and normalization of spatial memory. SSK1, however, displays a stronger protective effect against seizures. In short, SSK1 is a compelling, translationally viable option for senolysis in TLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, Temporal LobeSenotherapeuticsCellular SenescenceBehavior, AnimalStatus EpilepticusAnimalsDisease Models, AnimalMiceMaleHippocampusPilocarpineElectroencephalographyMice, Inbred C57BLThalamus

Stichwörter der Autor:innen

SSK1epileptogenesishippocampussenescence

Substanzen

PilocarpineSenotherapeutics

Autor:innen und Institutionen

  • Interdisciplinary Program in Neuroscience, Georgetown University, Washington, DC, USA.
  • Department of Pharmacology and Physiology, Georgetown University, Washington, DC, USA.

ORCID-Profile: David J McFall, Patrick A Forcelli

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institute of General Medical Sciences

Zitieren

APA

McFall, D. J., Hussain, A. I., Cho, M., & Forcelli, P. A. (2026). Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy. Epilepsia, 67(7), 3779-3790. https://doi.org/10.1002/epi.70226

Vancouver

McFall DJ, Hussain AI, Cho M, Forcelli PA. Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy. Epilepsia. 2026;67(7):3779-3790. doi:10.1002/epi.70226

BibTeX
@article{McFall2026,
  author = {McFall, David J and Hussain, Abbas I and Cho, Michelle and Forcelli, Patrick A},
  title = {Targeted senotherapy improves electrographic and behavioral outcomes in a mouse model of temporal lobe epilepsy},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {7},
  pages = {3779--3790},
  doi = {10.1002/epi.70226}
}
Kostenlos starten →